HLS Therapeutics Inc. revenue for the last year amounted to 63.07 M USD, the most of which — 64.23 M USD — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 59.03 M USD. The greatest contribution to the revenue figure was made by Canada — last year it brought HLS Therapeutics Inc. 40.01 M USD, and the year before that — 35.55 M USD.